Viewing Study NCT01829568


Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2026-01-03 @ 11:10 PM
Study NCT ID: NCT01829568
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-27
First Post: 2013-04-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module